SG Americas Securities LLC Makes New $147,000 Investment in National Research Co. (NASDAQ:NRC)

SG Americas Securities LLC bought a new position in National Research Co. (NASDAQ:NRC) in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor bought 3,727 shares of the company’s stock, valued at approximately $147,000.

Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Qube Research & Technologies Ltd bought a new position in National Research in the 3rd quarter worth $45,000. Lazard Asset Management LLC bought a new position in shares of National Research during the 1st quarter worth about $49,000. Tower Research Capital LLC TRC boosted its position in shares of National Research by 675.3% during the 1st quarter. Tower Research Capital LLC TRC now owns 1,349 shares of the company’s stock valued at $59,000 after acquiring an additional 1,175 shares in the last quarter. State of Wyoming boosted its position in shares of National Research by 154.0% during the 2nd quarter. State of Wyoming now owns 1,722 shares of the company’s stock valued at $75,000 after acquiring an additional 1,044 shares in the last quarter. Finally, Citigroup Inc. boosted its position in shares of National Research by 147.0% during the 1st quarter. Citigroup Inc. now owns 2,092 shares of the company’s stock valued at $91,000 after acquiring an additional 1,245 shares in the last quarter. Hedge funds and other institutional investors own 47.26% of the company’s stock.

Analyst Upgrades and Downgrades

Separately, TheStreet lowered shares of National Research from a “b-” rating to a “c+” rating in a research report on Thursday, January 11th.

National Research Price Performance

Shares of NRC stock opened at $34.36 on Wednesday. National Research Co. has a 1 year low of $33.68 and a 1 year high of $47.25. The firm’s 50 day moving average is $38.84 and its 200-day moving average is $40.30. The firm has a market capitalization of $819.49 million, a price-to-earnings ratio of 27.49 and a beta of 0.42. The company has a current ratio of 0.67, a quick ratio of 0.67 and a debt-to-equity ratio of 0.60.

National Research (NASDAQ:NRC) last issued its earnings results on Tuesday, February 13th. The company reported $0.36 EPS for the quarter. The firm had revenue of $38.00 million during the quarter. National Research had a net margin of 20.84% and a return on equity of 47.79%.

National Research Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Monday, April 15th. Investors of record on Friday, March 29th were issued a dividend of $0.12 per share. This represents a $0.48 annualized dividend and a yield of 1.40%. The ex-dividend date was Wednesday, March 27th. National Research’s payout ratio is 38.40%.

National Research Company Profile

National Research Corporation provides analytics and insights that facilitate measurement and enhancement of the patient and employee experience. Its portfolio of subscription-based solutions provides actionable information and analysis to healthcare organizations across a range of mission-critical, constituent-related elements, including patient experience, service recovery, care transitions, employee engagement, reputation management, and brand loyalty.